Advertisement
Home Tags Meningitis

Tag: Meningitis

A case of cryptococcal meningitis with false-negative cerebrospinal fluid culture results following receipt of capecitabine has been described in a case report published in the December issue of the Journal of Clinical Pharmacy and Therapeutics.

Antineoplastic Agent Obscures Diagnosis of Fungal Meningitis

HealthDay.com -
0
Cerebrospinal fluid culture results were negative following receipt of capecitabine
Drug-induced aseptic meningitis following trimethoprim use has been described in a research letter published online Nov. 20 in the International Journal of Rheumatic Diseases.

Trimethoprim-Induced Aseptic Meningitis Described

HealthDay.com -
0
Case report describes 87-year-old with 3 episodes; decreasing interval between dose, symptoms
Serogroup B meningococcal vaccination is recommended for adolescents and young adults aged 16 to 23 years to provide short-term protection from most strains of serogroup B meningococcal disease

MenB Vaccine Recommended for 16- to 23-Year-Olds

HealthDay.com -
0
Preferred age for serogroup B meningococcal vaccination is 16 to 18 years
For 11- to 15-year olds

Concomitant Administration of 9vHPV With MCV4/Tdap Feasible

HealthDay.com -
0
Noninferior to intermittent administration of vaccines for 11- to 15-year olds
The U.S. Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices has voted to issue a category B recommendation for use of two serogroup B meningococcal vaccines in patients aged 16 to 23 years for short-term disease prevention

ACIP Recommends MenB Vaccine for 16- to 23-Year-Olds

HealthDay.com -
0
Category B recommendation for short-term protection against meningitis for all aged 16 to 23
An investigational serogroup B meningococcal vaccine seems to have protected vaccinated individuals from the disease during an outbreak

Investigational MenB Vaccine Can Protect Individuals in Outbreak

HealthDay.com -
0
No serogroup B meningococcal disease cases in those who received MenB vaccine in university outbreak
The Bexsero vaccine has been approved by the U.S. Food and Drug Administration to prevent serogroup B meningococcal disease among people aged 10 through 25.

FDA Approves New Meningococcal Disease Vaccine

HealthDay.com -
0
Bexsero is the second vaccine approved in the past three months to prevent this disease
1234Page 4 of 4

EVEN MORE NEWS

POPULAR CATEGORY

© 2023 eHealthcare Solutions, LLC
2093 Philadelphia Pike #8370, Claymont, DE 19703
Ph: (609) 882-8887 | Fx: (425) 671-7796